Globus Medical, Inc. (GMED)
NYSE: GMED · Real-Time Price · USD
72.09
-0.47 (-0.64%)
Mar 31, 2025, 9:53 AM EDT - Market open
Globus Medical Revenue
In the year 2024, Globus Medical had annual revenue of $2.52B with 60.62% growth. Globus Medical had revenue of $657.29M in the quarter ending December 31, 2024, with 6.61% growth.
Revenue (ttm)
$2.52B
Revenue Growth
+60.62%
P/S Ratio
3.91
Revenue / Employee
$475,350
Employees
5,300
Market Cap
9.91B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 2.52B | 950.88M | 60.62% |
Dec 31, 2023 | 1.57B | 545.63M | 53.34% |
Dec 31, 2022 | 1.02B | 64.74M | 6.76% |
Dec 31, 2021 | 958.10M | 169.06M | 21.43% |
Dec 31, 2020 | 789.04M | 3.67M | 0.47% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
GMED News
- 9 days ago - NEVRO INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Nevro Corp. - NVRO - Business Wire
- 19 days ago - Globus Medical extends versatility of Advanced Materials Science™ anterior interbody portfolio with launch of COHERE™ ALIF Spacer and Modulus™ ALIF Blades - GlobeNewsWire
- 24 days ago - Globus Medical to feature ExcelsiusFlex™ for Total Knee Arthroplasty at the American Academy of Orthopedic Surgeons Annual Meeting - GlobeNewsWire
- 25 days ago - Globus Medical to participate in the Canaccord Genuity 2025 Musculoskeletal Conference - GlobeNewsWire
- 26 days ago - Nevro Reports Fourth-Quarter and Full-Year 2024 Financial Results - PRNewsWire
- 5 weeks ago - Globus Medical, Inc. (GMED) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Globus Medical Reports Fourth Quarter and Full Year 2024 Results - GlobeNewsWire
- 7 weeks ago - Globus Medical to Acquire Nevro Corp. to Expand Treatment Options for Patients - GlobeNewsWire